Cyclandelate

Known as: Benzeneacetic acid, alpha-hydroxy-, 3,3,5-trimethylcyclohexyl ester, 3,5,5-Trimethylcyclohexyl amygdalate, Cyclandelatum 
A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The prophylactic action of cyclandelate was investigated in a multicentre, randomized, placebo-controlled, parallel group study… (More)
Is this relevant?
1998
1998
The mechanisms of action of calcium antagonists in the prophylactic treatment of migraine remain unclear. The most likely… (More)
Is this relevant?
1998
1998
Cyclandelate is a vasodilating agent that, like papaverine, acts directly on the smooth muscles of blood vessels. The drug has… (More)
Is this relevant?
1996
1996
Cyclandelate inhibits calcium-induced contraction of vascular smooth muscle cells, platelet aggregation induced by thrombin… (More)
Is this relevant?
1995
1995
The aim of the present study was to ascertain the comparative efficacy of cyclandelate, a migraine prophylactic with calcium… (More)
Is this relevant?
1987
1987
In a double-blind, parallel-group randomised trial of 3 months’ duration, the efficacy of cyclandelate 800mg twice daily in… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
1987
1987
A double-blind, double-dummy clinical trial was conducted in which the efficacy of cyclandelate 1600mg daily was compared with… (More)
  • table I
  • table II
  • table III
  • table IV
  • table V
Is this relevant?
1977
1977
The treatment of cerebrovascular insufficiency and its many symptoms in the ever-increasing numbers of the aged, is of major… (More)
Is this relevant?
1977
1977
In order to assess the effect of cyclandelate on the abnormal permeability of the blood-retinal barrier which occurs in diabetic… (More)
Is this relevant?
1974
1974
Despite controversy about whether cerebral arteriosclerosis is a valid clinical entity and independent of senile dementia and/or… (More)
  • table III
Is this relevant?